Complement System Cascade

The complement system is a foundational pillar of your innate immune defense, a cascade of plasma proteins that acts with precision and speed to eliminate pathogens. Understanding this system is not only critical for grasping how your body fights infections but also for recognizing its role in autoimmune diseases and inflammation—concepts heavily emphasized on the MCAT and essential for clinical reasoning. Mastering its pathways and functions will allow you to predict immunological outcomes and tackle high-yield exam questions with confidence.

The Complement System: A Primer on Form and Function

The complement system is a set of over 30 circulating and membrane-bound proteins that work in a tightly regulated enzymatic cascade. Its primary function is to enhance, or "complement," the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism. Think of it as your body's rapid-response demolition and cleanup crew: it tags threats for destruction, summons reinforcements, and can directly punch holes in enemy cells. For the MCAT, you must know that complement proteins are mostly synthesized in the liver and circulate in an inactive state, becoming activated only upon encountering specific triggers.

The Three Activation Pathways: Converging on a Common Goal

Activation occurs through three distinct pathways—classical, lectin, and alternative—all engineered to generate the key enzyme of the cascade: C3 convertase. This convergence is a favorite MCAT concept, testing your ability to trace different immunological triggers to a unified effector mechanism.

1. The Classical Pathway: This is the antibody-dependent pathway. It is initiated when the C1 complex (C1q, C1r, C1s) binds to the Fc region of antibodies (IgM or IgG) that are already attached to a pathogen's surface. This binding activates C1s, which then cleaves C4 and C2 to form the C3 convertase, C4b2a.

1. The Lectin Pathway: This antibody-independent pathway is triggered by pattern recognition. Mannose-binding lectin (MBL) or ficolins bind directly to specific sugar patterns (e.g., mannose) on microbial surfaces. This complex activates associated proteases (MASP-1 and MASP-2), which mimic C1s and similarly cleave C4 and C2 to form the same C4b2a C3 convertase.

1. The Alternative Pathway: This pathway provides constant, low-level surveillance and is crucial for defense against novel pathogens. It is initiated by the spontaneous, slow hydrolysis of C3 in the plasma to form "tickover" C3(H₂O). This altered C3 can bind factor B, which is then cleaved by factor D to form the initial fluid-phase C3 convertase, C3(H₂O)Bb. This convertase cleaves more C3 to C3b, which can covalently bind to microbial surfaces. Surface-bound C3b then binds factor B, leading to factor D cleavage and the formation of the robust, membrane-bound alternative pathway C3 convertase, C3bBb.

All three pathways ultimately create a membrane-bound C3 convertase, which cleaves the central protein C3 into C3a and C3b, unleashing the system's effector functions.

Effector Functions: Opsonization, Inflammation, and Lysis

The cleavage of C3 is the major amplification step, producing fragments with three critical roles.

• Opsonization: The larger fragment, C3b, acts as a powerful opsonin. It covalently attaches to the pathogen surface, "tagging" it for engulfment by phagocytes (like macrophages and neutrophils) that possess receptors for C3b. This dramatically enhances the efficiency of phagocytosis.
• Inflammation: The small fragments C3a and C5a (generated later) are anaphylatoxins. They are potent chemoattractants that recruit inflammatory cells like neutrophils to the site of infection. They also increase vascular permeability and trigger mast cell degranulation, promoting the inflammatory response. On the MCAT, know that C5a is significantly more potent than C3a.
• Membrane Attack Complex (MAC) Formation: This is the lytic pathway. The generation of C3b by the C3 convertase allows for the formation of a C5 convertase (C4b2a3b or C3bBb3b). This enzyme cleaves C5 into C5a and C5b. C5b initiates the terminal sequence by binding C6 and C7. The C5b67 complex inserts into the microbial membrane. C8 then binds and facilitates the polymerization of multiple C9 molecules to form a pore-like membrane attack complex (C5b-C9). This pore disrupts osmotic balance, causing water and ion influx that leads to cell lysis and death.

Regulation: Preventing Friendly Fire

Given its destructive potential, the complement cascade is under stringent control to prevent damage to host tissues. Regulatory proteins exist at every step. For example:

• C1 inhibitor (C1INH) blocks the classical and lectin pathways.
• Factor I, with cofactors like factor H or membrane cofactor protein (MCP/CR1), inactivates C3b.
• Decay-accelerating factor (DAF/CD55) disassembles C3 convertases.
• CD59 (protectin) inhibits the assembly of the MAC on host cells.

Understanding these regulators is key for clinical scenarios; their deficiency leads to specific diseases.

Clinical Correlations: Complement Deficiencies and Dysregulation

Complement deficiencies vividly illustrate the system's importance and are classic board exam topics. Deficiencies in early classical pathway components (C1q, C2, C4) are strongly associated with autoimmune disorders like systemic lupus erythematosus (SLE), due to impaired clearance of immune complexes. Deficiencies in later components (C3, C5-C9) or properdin (a positive regulator of the alternative pathway) lead to increased susceptibility to recurrent bacterial infections, particularly with Neisseria species (e.g., meningitis, gonorrhea). For MCAT strategy, remember this association: terminal MAC component defects → Neisseria infections. Furthermore, uncontrolled complement activation contributes to pathologies like atypical hemolytic uremic syndrome (aHUS) and ischemia-reperfusion injury.

Common Pitfalls

1. Confusing the Initiators: Students often mix up what triggers each pathway. Remember: Classical needs antibody-antigen complexes; Lectin needs microbial sugar patterns; Alternative is spontaneous on microbial surfaces. A trap MCAT question might describe a novel pathogen with no prior immunity and ask which pathway responds first—the answer is the alternative (or lectin) pathway, not the classical.
2. Misidentifying the Convertases: The names and compositions are tricky. The classical/lectin C3 convertase is C4b2a. The alternative C3 convertase is C3bBb. Both cleave C3. The C5 convertases are simply these enzymes with an added C3b molecule: C4b2a3b and C3bBb3b. Drawing this out once will save you from memorization errors.
3. Overlooking Regulation: It's easy to focus only on activation. However, the clinical consequences of dysregulation are equally important. For example, know that paroxysmal nocturnal hemoglobinuria (PNH) results from a deficiency of DAF and CD59 on blood cells, making them susceptible to complement-mediated lysis.
4. Attributing Functions to the Wrong Fragment: C3a and C5a cause inflammation; C3b and its further cleavage product iC3b are for opsonization; the MAC (C5b-9) causes lysis. A common mistake is thinking C5b itself forms the pore—it's the initiator for the multi-protein MAC assembly.

Summary

• The complement system is a protease cascade of plasma proteins that provides a major mechanism for innate immune defense through three pathways: classical (antibody-triggered), lectin (pattern-recognition triggered), and alternative (spontaneously activated on microbial surfaces).
• All pathways converge on the formation of a C3 convertase, which cleaves C3 into C3a (pro-inflammatory) and C3b (opsonin).
• C3b tags pathogens for phagocytosis (opsonization), while C3a and C5a act as anaphylatoxins to recruit immune cells and promote inflammation.
• The terminal sequence results in the assembly of the membrane attack complex (C5b-C9), which forms a pore in pathogen membranes, leading to osmotic lysis.
• Tight regulation by host proteins is essential to prevent autologous damage; deficiencies in these regulators or cascade components lead to specific clinical syndromes, such as autoimmune disease or heightened susceptibility to bacterial infections.